High-dose chemotherapy with autologous stem-cell support in the treatment of high-risk, primary breast cancer.
D054598:Blue Cross Blue Shield Insurance Plans; D001943:Breast Neoplasms / Q000628:therapy*; D016022:Case-Control Studies; D002469:Cell Separation / Q000295:instrumentation / Q000379:methods; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D017277:Drug Approval; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D017063:Outcome Assessment, Health Care; D013673:Technology Assessment, Biomedical; D014182:Transplantation, Autologous; D014481:United States; D014486:United States Food and Drug Administration